Phase I, multiple, ascending-dose trial of ARRY 797 in volunteers.

Trial Profile

Phase I, multiple, ascending-dose trial of ARRY 797 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Feb 2009

At a glance

  • Drugs ARRY 797 (Primary)
  • Indications Ankylosing spondylitis; Cancer; Dental pain; Inflammation; Pain; Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Array BioPharma
  • Most Recent Events

    • 13 Feb 2009 Status changed from unconfirmed to completed.
    • 12 Nov 2008 Results were presented at the 2008 Annual European Congress of Rheumatology. Endpoints added. Link to ADNM 801116617 added.
    • 26 Nov 2007 As of November 2007, this trial is reportedly nearing completion.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top